Apex Healthcare Berhad Yönetim

Yönetim kriter kontrolleri 4/4

Apex Healthcare Berhad CEO'su Kirk Kee, May2010 tarihinde atandı, in görev süresi 14.5 yıldır. in toplam yıllık tazminatı MYR 283.27K olup, şirket hissesi ve opsiyonları dahil olmak üzere 18.3% maaş ve 81.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.18% ine doğrudan sahiptir ve bu hisseler MYR 22.01M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 10.3 yıl ve 6.5 yıldır.

Anahtar bilgiler

Kirk Kee

İcra Kurulu Başkanı

RM 283.3k

Toplam tazminat

CEO maaş yüzdesi	18.3%
CEO görev süresi	14.5yrs
CEO sahipliği	1.2%
Yönetim ortalama görev süresi	10.3yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

CEO Tazminat Analizi

Kirk Kee'un ücretlendirmesi Apex Healthcare Berhad'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	RM 89m
Mar 31 2024	n/a	n/a	RM 395m
Dec 31 2023	RM 283k	RM 52k	RM 398m
Sep 30 2023	n/a	n/a	RM 413m
Jun 30 2023	n/a	n/a	RM 415m
Mar 31 2023	n/a	n/a	RM 109m
Dec 31 2022	RM 321k	RM 51k	RM 101m
Sep 30 2022	n/a	n/a	RM 87m
Jun 30 2022	n/a	n/a	RM 74m
Mar 31 2022	n/a	n/a	RM 63m
Dec 31 2021	RM 289k	RM 57k	RM 59m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 53m
Mar 31 2021	n/a	n/a	RM 54m
Dec 31 2020	RM 367k	RM 101k	RM 56m
Sep 30 2020	n/a	n/a	RM 56m
Jun 30 2020	n/a	n/a	RM 56m
Mar 31 2020	n/a	n/a	RM 56m
Dec 31 2019	RM 341k	RM 99k	RM 53m
Sep 30 2019	n/a	n/a	RM 56m
Jun 30 2019	n/a	n/a	RM 56m
Mar 31 2019	n/a	n/a	RM 57m
Dec 31 2018	RM 539k	RM 100k	RM 59m
Sep 30 2018	n/a	n/a	RM 55m
Jun 30 2018	n/a	n/a	RM 51m
Mar 31 2018	n/a	n/a	RM 48m
Dec 31 2017	RM 366k	RM 105k	RM 44m

Tazminat ve Piyasa: Kirk 'nin toplam tazminatı ($USD 63.51K ), MY pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 190.86K ).

Tazminat ve Kazançlar: Kirk 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Kirk Kee (62 yo)

14.5yrs

Görev süresi

RM 283,273

Tazminat

Dr. Kirk Chin Kee has been the Chief Executive Officer and Chairman of Apex Healthcare Berhad since May 19, 2010 and served as its Managing Director since March 3, 2000. He has been Executive Director of A...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kirk Kee	Chairman & CEO	14.5yrs	RM 283.27k	1.18% MYR 22.0m
Woon Chiew	CFO & Joint Company Secretary	10.3yrs	Veri yok	Veri yok
Hing Tan	Chief Operating Officer of Distribution Group	2.7yrs	Veri yok	Veri yok
Kien Ch'ng	Chief Operating Officer of Manufacturing Group	9.8yrs	Veri yok	Veri yok
Yoke Chan	Joint Company Secretary	10.8yrs	Veri yok	Veri yok

10.3yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: AHEALTH 'un yönetim ekibi deneyimli ve deneyimlidir ( 10.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kirk Kee	Chairman & CEO	24.8yrs	RM 283.27k	1.18% MYR 22.0m
Robert Millner	Non-Independent Non-Executive Director	24.8yrs	RM 60.14k	0.061% MYR 1.1m
Khai Leong	Independent Non-Executive Director	3.3yrs	RM 102.00k	0.23% MYR 4.2m
Kirk Kee	Non-Independent Non-Executive Director	8.5yrs	RM 85.00k	Veri yok
Ah Phang	Independent Non-Executive Director	6.5yrs	RM 102.00k	0.0021% MYR 38.6k
Seng Yap	Independent & Non Executive Director	1.5yrs	RM 69.84k	Veri yok
Wat Le	Independent & Non-Executive Director	1.5yrs	RM 56.10k	0.0042% MYR 77.5k

6.5yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: AHEALTH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Apex Healthcare Berhad Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Recent updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

New 90-day high: RM3.78

Apex Healthcare Berhad to Be Deleted from Other OTC

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Third quarter 2020 earnings released: EPS RM0.03

Upcoming Dividend of RM0.017 Per Share